Chikungunya: un virus que nos acecha

Autores/as

  • Eugenia Corrales Aguilar Universidad de Costa Rica
  • Adriana Troyo Universidad de Costa Rica
  • Ólger Calderón Arguedas Universidad de Costa Rica

DOI:

https://doi.org/10.51481/amc.v57i1.863

Palabras clave:

chikungunya, virus, patogénesis, Aedes, Costa Rica

Resumen

El virus chikungunya representa una amenaza para Costa Rica. Este arbovirus ha sido introducido al continente americano desde finales de 2013. Debido a sus características epidemiológicas y virológicas, y a la presencia de sus vectores en el país, este virus puede llegar a convertirse en la nueva enfermedad endémica de Costa Rica. Aunque el chikungunya tiene una baja tasa de mortalidad, su alta tasa de ataque podría colapsar el sistema de salud nacional durante una epidemia. En esta revisión se resume aspectos clínicos, virológicos, epidemiológicos y entomológicos relacionados con esta virosis, para identificar, diagnosticar y diferenciar posibles casos de fiebre por chikungunya en el país. Además, se enfatiza en el control epidemiológico y de vectores, para prevenir epidemias de esta enfermedad en Costa Rica.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953. Trans R Soc Trop Med Hyg. 1955;49(1):28–32.

Enserink M. Infectious diseases. Massive outbreak draws fresh attention to little-known virus. Science. 2006;311(5764):1085.

Weaver SC. Arrival of chikungunya virus in the new world: prospects for spread and impact on public health. PLoS Negl Trop Dis. 2014;8(6):e2921.

Charrel RN, de Lamballerie X. Chikungunya virus in north-eastern Italy: a consequence of seasonal synchronicity. Euro Surveill:2008;13(1).

Grandadam M, Caro V, Plumet S, Thiberge JM, Souarès Y, Failloux A-B, et al. Chikungunya virus, southeastern France. Emerg Inf Dis. 2011;17(5):910–3.

Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007;370(9602):1840–6.

Cassadou S, Boucau S, Petit-Sinturel M, Huc P, Leparc-Goffart I, Ledrans M. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill: 2014;19(13).

Fischer M, Staples JE. Notes from the field: chikungunya virus spreads in the Americas - Caribbean and South America, 2013-2014. MMWR. Morb Mortal Wkly Rep. 2014;63(22):500–1.

Taubitz W, Cramer JP, Kapaun A, Pfeffer M, Drosten C, Dobler G, et al. Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis 2007;45(1):e1–4.

Lee RCH, Hapuarachchi HC, Chen KC, Hussain KM, Chen H, Low SL, et al. Mosquito cellular factors and functions in mediating the infectious entry of chikungunya virus. PLoS Negl Trop Dis. 2013;7(2):e2050.

Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, et al. Characterization of reemerging chikungunya virus. PLoS Path. 2007;3(6):e89.

Solignat M, Gay B, Higgs S, Briant L, Devaux C. Replication cycle of chikungunya: a re-emerging arbovirus. Virol. 2009;393(2):183–97.

Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney M-C, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3(7):e263.

Powers AM, Brault AC, Tesh RB, Weaver SC. Re-emergence of Chikungunya and O’nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. JGen Virol. 2000;81(Pt 2):471–9.

De Lamballerie X, Leroy E, Charrel RN, Ttsetsarkin K, Higgs S, Gould EA. Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virol J. 2008;5:33.

Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Path. 2007;3(12):e201.

Vazeille M, Moutailler S, Coudrier D, Rousseaux C, Khun H, Huerre M, et al. Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PloS one. 2007;2(11):e1168.

Mansuy J-M, Grouteau E, Mengelle C, Claudet I, Izopet J. Chikungunya in the Caribbean--threat for Europe. Emerg Inf Dis. 2014;20(8):1423–5.

Van Bortel W, Dorleans F, Rosine J, Blateau a, Rousset D, Matheus S, et al. Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill. 2014;19(13).

Lanciotti RS, Valadere AM. Transcontinental movement of Asian genotype chikungunya virus. Emerg Infect Dis. 2014;20(8):1400–2.

Thiberville S-D, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould E a, Roques P, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013;99(3):345–70.

Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L. Chikungunya virus infection: an overview. New Microbiol. 2013;36(3):211– 27.

Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. Vectors of Chikungunya virus in Senegal: current data and transmission cycles.Am J Trop Med Hyg 1999;60(2):281–6.

Pialoux G, Gaüzère B-A, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7(5):319–27.

Brès P, Camicas JL, Cornet M, Robin Y, Taufflieb R. [Epidemiology of arbovirus diseases in Senegal]. Bull Soc Pathol Exot Filiales. 1969;62(2):253–9.

Peiris JS, Dittus WP, Ratnayake CB. Seroepidemiology of dengue and other arboviruses in a natural population of toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka. J Med Primatol. 1993;22(4):240–5.

Anon. Encyclopedia of Arthropod-transmitted Infections of Man and Domesticated Animals. CABI; 2001:579.

Parola P, de Lamballerie X, Jourdan J, Rovery C, Vaillant V, Minodier P, et al. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg infect dis. 2006;12(10):1493–9.

Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009;49(6):942–8.

Richards SL, Ponnusamy L, Unnasch TR, Hassan HK, Apperson CS. Hostfeeding patterns of Aedes albopictus (Diptera: Culicidae) in relation to availability of human and domestic animals in suburban landscapes of central North Carolina. J Med Entomol. 2006;43(3):543–51.

Richards SL, Anderson SL, Smartt CT. Vector competence of Florida mosquito es for chikungunya virus. JVectorEcol . 2010;35(2):439–43.

Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol 2010;8(7):491–500.

Dubrulle M, Mousson L, Moutailler S, Vazeille M, Failloux A-B. Chikungunya virus and Aedes mosquitoes: saliva is infectious as soon as two days after oral infection. PloS one. 2009;4(6):e5895.

Vega-Rúa A, Zouache K, Girod R, Failloux A-B, Lourenço-de-Oliveira R. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus. J Virol. 2014;88(11):6294–306.

Vazeille M, Mousson L, Failloux A-B. Failure to demonstrate experimental vertical transmission of the epidemic strain of Chikungunya virus in Aedes albopictus from La Réunion Island, Indian Ocean. Mem Inst Oswaldo Cruz. 2009;104(4):632–5.

Chahar HS, Bharaj P, Dar L, Guleria R, Kabra SK, Broor S. Co-infections with chikungunya virus and dengue virus in Delhi, India. Emerg Infect Dis. 2009;15(7):1077–80.

Vazeille M, Mousson L, Martin E, Failloux A-B. Orally co-Infected Aedes albopictus from La Reunion Island, Indian Ocean, can deliver both dengue

and chikungunya infectious viral particles in their saliva. PLoS Negl Trop Dis. 2010;4(6):e706.

Suhrbier A, Jaffar-Bandjee M-C, Gasque P. Arthritogenic alphaviruses--an overview. Nat Rev Rheumatol. 2012;8(7):420–9.

Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis. 2012;6(3):e1446.

Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Path. 2008;4(2):e29.

Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM. The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Inf Dis. 2011;204(1):115– 23.

Jaffar-Bandjee MC, Das T, Hoarau JJ, Krejbich Trotot P, Denizot M, et al. Chikungunya virus takes centre stage in virally induced arthritis: possible cellular and molecular mechanisms to pathogenesis. Microbes Infect. 2009;11(14-15):1206–18.

Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a reemerging virus. Lancet. 2012;379(9816):662–71.

Couderc T, Lecuit M. Focus on Chikungunya pathophysiology in human and animal models. Microbes Infect. 2009;11(14-15):1197–205.

Waymouth HE, Zoutman DE, Towheed TE. Chikungunya-related arthritis: case report and review of the literature. Semin ArthritisRheum. 2013;43(2):273–8.

Hoarau J-J, Jaffar Bandjee M-C, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184(10):5914–27.

Hochedez P, Jaureguiberry S, Debruyne M, Bossi P, Hausfater P, Brucker G, et al. Chikungunya infection in travelers. Emerg Infect Dis. 2006;12(10):1565–7.

Saxena SK, Singh M, Mishra N, Lakshmi V. Resurgence of chikungunya virus in India: an emerging threat. Euro surveill. 2006;11(8):E060810.2.

Quatresous I. Chikungunya outbreak in Reunion, a French overseas department. Euro surveill. 2006;11(2):E060202.1.

Brighton SW, Prozesky OW, de la Harpe AL. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J.1983;63(9):313–5.

Kennedy AC, Fleming J, Solomon L. Chikungunya viral arthropathy: a clinical description. The JRheumatol. 1980;7(2):231–6.

Ravi V. Re-emergence of chikungunya virus in India. Indian JMed Microbiol. 2006;24(2):83–4.

Lebrun G, Chadda K, Reboux A-H, Martinet O, Gaüzère B-A. Guillain-Barré syndrome after chikungunya infection. Emerg Infect Dis. 2009;15(3):495–6.

Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O,

Quenel P, et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect. 2009;137(4):534–41.

Weaver SC, Osorio JE, Livengood J a, Chen R, Stinchcomb DT. Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines. 2012;11(9):1087–101.

Panning M, Wichmann D, Grywna K, Annan A, Wijesinghe S, Kularatne SAM, et al. No evidence of chikungunya virus and antibodies shortly before the outbreak on Sri Lanka. Med Microbiol Immunol. 2009;198(2):103–6.

Hasebe F, Parquet MC, Pandey BD, Mathenge EGM, Morita K, Balasubramaniam V, et al. Combined detection and genotyping of Chikungunya virus by a specific reverse transcription-polymerase chain reaction. J Med Virol. 2002;67(3):370–4.

Carletti F, Bordi L, Chiappini R, Ippolito G, Sciarrone MR, Capobianchi MR, Di Caro A, Castilletti C. Rapid detection and quantification of Chikungunya virus

by a one-step reverse transcription polymerase chain reaction real-time assay. Am J Trop Med Hyg. 2007;77(3):521–4.

Litzba N, Schuffenecker I, Zeller H, Drosten C, Emmerich P, Charrel R,et al. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Meth. 2008;149(1):175–9.

Blackburn NK, Besselaar TG, Gibson G. Antigenic relationship between chikungunya virus strains and o’nyong nyong virus using monoclonal antibodies. Res Virol. 146(1):69–73.

Lee VJ, Lye DCB, Sun Y, Fernandez G, Ong A, Leo YS. Predictive value of simple clinical and laboratory variables for dengue hemorrhagic fever in adults. J Clin Virol. 2008;42(1):34–9.

Ingram PR, Mahadevan M, Fisher DA. Dengue management: practical and safe hospital-based outpatient care. Trans R Soc Trop Med Hyg 2009;103(2):203–5.

Laoprasopwattana K, Kaewjungwad L, Jarumanokul R, Geater A. Differential diagnosis of Chikungunya, dengue viral infection and other acute febrile illnesses in children. Pediatr Infect Dis J. 2012;31(5):459–63.

Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S. A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal, India. Am J Trop Med Hyg. 2012;86(4):720–3.

Lee VJ, Chow A, Zheng X, Carrasco LR, Cook AR, Lye DC, et al. Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis. 2012;6(9):e1786.

Ravichandran R, Manian M. Ribavirin therapy for Chikungunya arthritis. J Infect Dev Ctries. 2008;2(2):140–2.

Briolant S, Garin D, Scaramozzino N, Jouan A, Crance JM. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res. 2004;61(2):111–7.

Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, et al. Prophylaxis and therapy for Chikungunya virus infection. J Inf Dis. 2009;200(4):516–23.

Edelman R, Tacket CO, Wasserman SS, Bodison SA, Perry JG, Mangiafico JA. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2000;62(6):681–5.

Wang E, Kim DY, Weaver SC, Frolov I. Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response. J Virol. 2011;85(17):9249–52.

Sharma A, Gupta P, Maheshwari RK. Inactivation of Chikungunya virus by 1,5 iodonapthyl azide. Virol J. 2012;9:301.

Akahata W, Yang Z-Y, Andersen H, Sun S, Holdaway HA, Kong W-P, et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med. 2010;16(3):334–8.

Mallilankaraman K, Shedlock DJ, Bao H, Kawalekar OU, Fagone P, Ramanathan AA, et al. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. PLoS Negl Trop Dis. 2011;5(1):e928.

Cavrini F, Gaibani P, Pierro AM, Rossini G, Landini MP, Sambri V. Chikungunya: an emerging and spreading arthropod-borne viral disease. J Infect Dev Ctries. 2009;3(10):744–52.

Calderón-Arguedas Ó, Avendaño A, López-Sánchez W, Troyo A. Expansion of Aedes albopictus skull in Costa Rica. Rev Ibero-Latinoam Parasitol. 2010;69:220–222.

Calderón Arguedas O, Troyo A, Avendaño A, Gutiérrez M. Aedes albopictus (Skuse) in the Huetar Atlantic Region of Costa Rica. Rev Costarric Salud Pública. 2012;21(2):76–80.

Mena N, Troyo A, Bonilla-Carrión R, Calderón-Arguedas Ó. Factores asociados con la incidencia de dengue en Costa Rica. Rev Panam Salud Pública. 2011;29(4):234–242.

Descargas

Publicado

2015-01-30 — Actualizado el 2015-01-30

Versiones

Cómo citar

Aguilar, E. C., Troyo, A., & Arguedas, Ólger C. (2015). Chikungunya: un virus que nos acecha. Acta Médica Costarricense, 57(1), 7–15. https://doi.org/10.51481/amc.v57i1.863